Home
Conditions
Macular Degeneration

Clinical trial condition

Macular Degeneration

Explore clinical trials studying Macular Degeneration. Study availability and eligibility vary by location and protocol.

392 public trials 45 recruiting studies

Refine in advanced search Browse all conditions

Macular Degeneration trial results

Completed

A Study to Evaluate THR-317 and Ranibizumab Combination Treatment for Diabetic Macular Oedema (DME)

NCT03499223

Conditions: Cardiovascular Diseases, Diabetes Complications, Diabetes Mellitus, +12 more
Locations: CHU Brugmann Brussels, Belgium

UZ Leuven Leuven, Belgium

Centre Rétine Gallien Bordeaux, France

Centre Hospitalier Intercommunal de Créteil Créteil, France

View all 37 locations

View Trial Details

Completed

Bloodstream Absorption of Avastin and Lucentis After Injection Into the Eye

NCT01661946

Conditions: Cardiovascular Diseases, Diabetes Complications, Diabetes Mellitus, +10 more
Locations: Hotel Dieu Hospital Kingston, Ontario, Canada

View Trial Details

Completed

Dosing Study of Ranibizumab for Diabetic Retinal and Macular Edema

NCT01476449

Conditions: Cardiovascular Diseases, Diabetes Complications, Diabetes Mellitus, +9 more
Locations: Retina Vitreous Associates of Florida Clearwater, Florida, United States

Retina Vitreous Associates of Florida St. Petersburg, Florida, United States

View Trial Details

Completed

Inner Nuclear Macular Microcyst is a Risk Factor for Macular Cystoid Changes After Phacoemulsification in Eyes With Previous Vitrectomy and Macular Pucker Removal

NCT03934190

Conditions: Epiretinal Membrane, Eye Diseases, Macular Cyst, +5 more
Locations: Not specified

View Trial Details

Completed

Intravitreal Aflibercept Injection for Radiation Retinopathy

NCT01579760

Conditions: Eye Diseases, Macular Degeneration, Macular Edema, +3 more
Locations: Washington University School of Medicine St Louis, Missouri, United States

Retina Consultants of Houston Houston, Texas, United States

View Trial Details

Completed

A Study of the Safety and Efficacy of a New Treatment for Macular Edema Resulting From Retinal Vein Occlusion

NCT00168324

Conditions: Cardiovascular Diseases, Embolism and Thrombosis, Eye Diseases, +8 more
Locations: Los Angeles, California, United States

Sydney, Australia

Graz, Austria

Halifax, Nova Scotia, Canada

View all 13 locations

View Trial Details

Completed

A Study of the Safety and Efficacy of a New Treatment for Macular Edema Resulting From Retinal Vein Occlusion

NCT00168298

Conditions: Cardiovascular Diseases, Embolism and Thrombosis, Eye Diseases, +8 more
Locations: Houston, Texas, United States

São Paulo, Brazil

Mississauga, Ontario, Canada

Bogotá, Colombia

View all 13 locations

View Trial Details

Completed

A Safety and Efficacy Study to Assess OZURDEX® in Patients With Macular Oedema Secondary to Retinal Vein Occlusion (RVO)

NCT01571557

Conditions: Cardiovascular Diseases, Embolism and Thrombosis, Eye Diseases, +8 more
Locations: Berlin, Germany

View Trial Details

Completed

Safety and Efficacy Study of Ozurdex® Compared to Lucentis® in Patients With Branch Retinal Vein Occlusion

NCT01427751

Conditions: Cardiovascular Diseases, Embolism and Thrombosis, Eye Diseases, +8 more
Locations: Paris, France

Munich, Germany

Tel Aviv, Israel

Milan, Italy

View Trial Details

Completed

A Retrospective Study of Anti-Vascular Endothelial Growth Factor (VEGF) Injections for Retinal Vein Occlusion or Diabetic Macular Edema

NCT01918371

Conditions: Cardiovascular Diseases, Embolism and Thrombosis, Eye Diseases, +8 more
Locations: San Antonio, Texas, United States

View Trial Details

Macular Degeneration

Macular Degeneration trial results

Related conditions